The algal metabolite enhanced the degradation of HIF-1α in breast cancer T47D cells, with an IC50 value as low as 0.4 μM, exhibiting selective anticancer effects under hypoxic conditions without affecting normoxic cell growth [276]. Here, HIF1A is linked to breast carcinoma.